215 related articles for article (PubMed ID: 10472615)
1. [Neuroleptic malignant syndrome associated with olanzapine].
García López MM; Ciprés L; de Cendra E; Vilalta Franch J
Med Clin (Barc); 1999 Sep; 113(6):239. PubMed ID: 10472615
[No Abstract] [Full Text] [Related]
2. [Malignant neuroleptic syndrome in treatment with the new, atypical antipsychotic agents, risperidone and olanzapine].
Gram LF
Ugeskr Laeger; 2000 Mar; 162(13):1914-5. PubMed ID: 10765710
[No Abstract] [Full Text] [Related]
3. Olanzapine-induced neuroleptic malignant syndrome.
Burkhard PR; Vingerhoets FJ; Alberque C; Landis T
Arch Gen Psychiatry; 1999 Jan; 56(1):101-2. PubMed ID: 9892264
[No Abstract] [Full Text] [Related]
4. Neuroleptic malignant syndrome after the initiation of olanzapine.
Levenson JL
J Clin Psychopharmacol; 1999 Oct; 19(5):477-8. PubMed ID: 10505593
[No Abstract] [Full Text] [Related]
5. [Neuroleptic malignant syndrome in a patient treated with olanzapine].
Horni G; Meirik K; Lund MB
Tidsskr Nor Laegeforen; 2003 Oct; 123(20):2867-9. PubMed ID: 14600711
[TBL] [Abstract][Full Text] [Related]
6. Case report: possible neuroleptic malignant syndrome associated with olanzapine.
Moltz DA; Coeytaux RR
J Clin Psychopharmacol; 1998 Dec; 18(6):485-6. PubMed ID: 9864084
[No Abstract] [Full Text] [Related]
7. Atypical neuroleptic malignant syndrome associated with olanzapine.
Reeves RR; Torres RA; Liberto V; Hart RH
Pharmacotherapy; 2002 May; 22(5):641-4. PubMed ID: 12013364
[TBL] [Abstract][Full Text] [Related]
8. Recovery from new-onset diabetes in a schizophrenic man after withdrawal of olanzapine.
Melkersson K; Hulting AL
Psychosomatics; 2002; 43(1):67-70. PubMed ID: 11927762
[No Abstract] [Full Text] [Related]
9. Olanzapine-induced retarded ejaculation: role of paroxetine comedication? A case report.
Bizouard P; Vandel S; Kantelip JP
Therapie; 2001; 56(4):443-5. PubMed ID: 11677871
[No Abstract] [Full Text] [Related]
10. Neuroleptic malignant syndrome associated with olanzapine therapy: a case report.
Stanfield SC; Privette T
J Emerg Med; 2000 Nov; 19(4):355-7. PubMed ID: 11074330
[TBL] [Abstract][Full Text] [Related]
11. Neuropletic malignant syndrome and olanzapine.
Sierra-Biddle D; Herran A; Diez-Aja S; Gonzalez-Mata JM; Vidal E; Diez-Manrique F; Vazquez-Barquero JL
J Clin Psychopharmacol; 2000 Dec; 20(6):704-5. PubMed ID: 11106147
[No Abstract] [Full Text] [Related]
12. [Neuroleptic malignant syndrome and atypical antipsychotics].
Canora Lebrato J; Bermúdez García JM; Alvarez García ML; Rico Irles J
Med Clin (Barc); 2000 Sep; 115(7):279. PubMed ID: 11013157
[No Abstract] [Full Text] [Related]
13. Olanzapine and neuroleptic malignant syndrome.
Tofler I
Psychosomatics; 2002; 43(6):505-6; author reply 506. PubMed ID: 12444237
[No Abstract] [Full Text] [Related]
14. Atypical antipsychotics and neuroleptic malignant syndrome.
Kohen D; Bristow MF
Br J Psychiatry; 1999 Oct; 175():392-3. PubMed ID: 10789314
[No Abstract] [Full Text] [Related]
15. Neuroleptic malignant syndrome associated with olanzapine therapy.
Apple JE; Van Hauer G
Psychosomatics; 1999; 40(3):267-8. PubMed ID: 10341541
[No Abstract] [Full Text] [Related]
16. Olanzapine and NMS.
Hickey C; Stewart C; Lippmann S
Psychiatr Serv; 1999 Jun; 50(6):836-7. PubMed ID: 10375159
[No Abstract] [Full Text] [Related]
17. Possible neuroleptic malignant syndrome associated with olanzapine.
Nyfort-Hansen K; Alderman CP
Ann Pharmacother; 2000 May; 34(5):667. PubMed ID: 10852098
[No Abstract] [Full Text] [Related]
18. Neuroleptic malignant syndrome during olanzapine and levomepromazine treatment.
Järventausta K; Leinonen E
Acta Psychiatr Scand; 2000 Sep; 102(3):231-3. PubMed ID: 11008860
[TBL] [Abstract][Full Text] [Related]
19. Olanzapine associated weight gain, hyperglycemia and neuroleptic malignant syndrome: case report.
Malyuk R; Gibson B; Procyshyn RM; Kang N
Int J Geriatr Psychiatry; 2002 Apr; 17(4):326-8. PubMed ID: 11994885
[TBL] [Abstract][Full Text] [Related]
20. Olanzapine induced neuroleptic malignant syndrome--a case review.
Kogoj A; Velikonja I
Hum Psychopharmacol; 2003 Jun; 18(4):301-9. PubMed ID: 12766935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]